Logo

Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical devic… read more

Healthcare

Biotechnology

3 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$2.49

Price

+0.40%

$0.01

Market Cap

$134.348m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$2.944m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$69.699m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.82

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$295k

$42.825m

Assets

$42.530m

Liabilities

$1.970m

Debt
Debt to Assets

4.6%

-

Debt to EBITDA
Free Cash Flow

-$59.701m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases